Ad hoc announcement pursuant to art. 53 SIX Swiss Exchange Listing Rules Company aims to accelerate access to much-needed biosimilar to reference medicine Enbrel®* for US patients with disabling ...

Novartis will invest $23bn in US-based manufacturing and research and development (R&D) over the next five years, becoming ...

The sector has seen billions in merger and acquisition activity in recent years; a September 2024 analysis by Insight ...

President Donald Trump on Tuesday (Apr 8) said the United States will soon announce a “major” tariff on pharmaceutical ...

AbbVie’s Skyrizi and Rinvoq were practically unshakeable atop the monthly TV drug ad spending rankings, ultimately leading ...

Nvidia GTC 2025 Live: Blackwell in Full Production and Demand 'Is Incredible,' Says Huang; Next-Gen Rubin System To Launch in 2026 ...

Sarepta and Roche will share the monitors' findings with EMA to resolve a temporary hold. Elsewhere, Allakos agreed to a ...

Key Insights The considerable ownership by individual investors in Novartis indicates that they collectively have ...

Additionally, Voyager announced it will host a live webcast recapping key AD/PD™ 2025 data at 4:30 p.m. ET on Monday ... AstraZeneca Rare Disease; Novartis Pharma AG; and Neurocrine Biosciences, Inc.

A Novartis sign hangs on the side of an office building in Cambridge, Massachusetts. 32,789 people played the daily Crossword recently. Can you solve it faster than others?32,789 people played the ...

The best ad blockers are unfortunately very necessary to survive on the modern internet. It doesn't matter which sites you browse, there's the risk of being harassed by pop-ups, tracker cookies ...